Adderall, a drug most commonly used to treat ADHD, is comprised of two amphetamine salts.
Law’s story said the positive test will not result in an MLB suspension, but will make Gray subject to additional follow-up testing once he starts his professional career. Law also wrote that one league source did not think it would hurt Gray’s draft stock, and Law even suggested it could help Gray go No. 1 overall, with the test potentially leading to a lower bonus for the Sooner junior.
Of more immediate concern is Gray’s status for this weekend’s Super Regional series at LSU. Adderall – considered a stimulant – is banned by the NCAA. Yet this test was conducted by Major League Baseball, not the NCAA.
The University of Oklahoma released this statement addressing Gray’s eligibility Monday:
“All University of Oklahoma student-athletes are subject to institutional and NCAA drug testing and are subject to corrective action relative to those policies. At this time, we are able to confirm that Jonathan Gray is eligible to compete for the University of Oklahoma baseball program.”
Aside from treating ADHD, Adderall can be used by athletes and even test-taking students to increase focus, improve wakefulness and assist in weight loss.
Law said that sources indicated that Gray did not have a therapeutic exemption for the drug.
In his latest MLB mock draft, updated Monday, Law had Gray going at No. 4 overall, to the Minnesota Twins.
Houston and the Chicago Cubs, which pick 1-2, have scouted Gray heavily throughout this season.
Gray has been one of the nation’s most dominant pitchers, currently standing 10-2 with a 1.59 earned run average. His 138 strikeouts rank No. 2 among Division I starters.
He went the distance, striking out 11, in OU’s 7-3 win over Coastal Carolina in the first game of last week’s regional at Virginia Tech.